Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01663896 · ClinicalTrials.gov registry record
Observational Study of OCT in a Patients Undergoing FFR
A clinical trial of Coronary Artery Disease, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 418
- Enrollment target
- 20
- Study locations
NCT01663896: Completed study of Coronary Artery Disease, sponsored by Abbott Medical Devices.
NCT01663896 is a study of Coronary Artery Disease that has completed, run by Abbott Medical Devices. The registered enrollment target is 418 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (67% lower). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01663896, a study of Coronary Artery Disease, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 418 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to define and evaluate optical coherence tomography (OCT) stent guidance parameters through prospective data collection in percutaneous coronary intervention (PCI) procedures of de novo lesions.
Primary Outcome
Incidence of OCT peri-procedural guidance parameter(s) for stenting and their relation to patient outcomes in-hospital.
Conditions Studied
Interventions
- DEVICE OCT stent guidance
Study Locations (20)
Texas
- Heart Hospital of Austin - Austin
- Dallas VA Medical Center - Dallas
- University of Texas Medical Branch at Galveston - Galveston
Other
- Med. Univ. Vienna - Vienna
- OLV Hospital - Aalst
- Gasthuisberg Leuven - Leuven
Kentucky
- Central Baptist Hospital - Lexington
- Baptist Health East - Louisville
Alabama
- University Hospital - Univ. of Alabama at Birmingham (UAB) - Birmingham
California
- Scripps Clinic, Green Hospital - La Jolla
Florida
- Florida Hospital Orlando - Orlando
Georgia
- Emory University Hospital - Atlanta
Illinois
- Loyola University Chicago - Maywood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 418 participants |
| Start Date | 2012-12-11 |
| Est. Completion | 2015-10 |
What the finished NCT01663896 record still lists
NCT01663896 is an observational study that tracks outcomes without assigning an intervention. The registered 418 participants enrollment target is mid-sized for trials with a published cap, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which OCT stent guidance is the first listed.
NCT01663896 names 20 study sites across 15 states, led by Texas, Other, Kentucky.
Frequently Asked Questions
What is clinical trial NCT01663896 about?
NCT01663896 is a clinical study titled "Observational Study of OCT in a Patients Undergoing FFR". The purpose of this study is to define and evaluate optical coherence tomography (OCT) stent guidance parameters through prospective data collection in percutaneous coronary intervention (PCI) procedures of de novo lesions.
What is the current status of trial NCT01663896?
This trial is currently completed. The enrollment target is 418 participants. The study started on 2012-12-11. Estimated completion is 2015-10.
What conditions does trial NCT01663896 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT01663896?
The interventions under investigation include: OCT stent guidance (DEVICE).
Who is sponsoring clinical trial NCT01663896?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01663896 being conducted?
This trial has 20 study locations across Alabama, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01663896's enrollment target sits among peer trials
418 86th of 219 higher than 134 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03135886 · 418 participants · NA
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
- NCT05579639 · 419 participants · Phase 2
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
- NCT06169735 · 417 participants · Phase 4
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
- NCT06699901 · 417 participants
Antibiotic Concentrations After MassivE Transfusion Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI